top of page
Biosciences
Offspring
Insights & Updates
Every Failed Program Looked Promising Once
Drug discovery has always involved making high-stakes decisions before all the answers are available. The challenge for R&D leadership is determining which uncertainties are acceptable, and which are systemic liabilities capable of derailing an entire program at the clinical threshold.
Featured
Search
Beyond the Checklist: Strategic TMAs for Definitive Tissue Cross-Reactivity
Executed strategically, using a specifically curated Tissue Microarray (TMA), TCR studies provide a rich dataset that provides "Deep Insights" into novel therapeutic antibodies, their comparative performance, and their associated risk in human patient trials.
evadanielson55
May 264 min read
bottom of page